Cargando…

The safety and short‐term outcomes of allogeneic hematopoietic stem cell transplantation with donor vaccination for COVID‐19

Detalles Bibliográficos
Autores principales:	Ding, Yihan, Shen, Yifan, Fan, Yi, Chen, Jia, Xu, Yang, Wu, Depei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534375/ https://www.ncbi.nlm.nih.gov/pubmed/36226252 http://dx.doi.org/10.1002/mco2.179

Ejemplares similares

Allogeneic hematopoietic stem cell transplantation from non-sibling 10/10 HLA-matched related donors: a single-center experience
por: Shen, Yaoyao, et al.
Publicado: (2021)

Acute liver failure associated with human adenovirus infection after allogeneic hematopoietic stem cell transplantation
por: Lin, Zhimin, et al.
Publicado: (2023)

Donor–Recipient Story in Allogeneic Hematopoietic Stem Cell Transplantation
por: Kum, Elena, et al.
Publicado: (2021)

Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag
por: Tang, Cen, et al.
Publicado: (2018)

Allogeneic hematopoietic stem cell transplantation for acute leukemia with Gilbert's syndrome
por: Yu, Guo-Pan, et al.
Publicado: (2011)

Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation
por: Song, Yuan, et al.
Publicado: (2020)

Donor Cell Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation
por: Khattab, Ahmed, et al.
Publicado: (2023)

Transmission of Human T-Lymphotropic Virus Type I to Donor-Origin T Cells During Allogeneic Hematopoietic Stem Cell Transplantation
por: Hirosawa, Makoto, et al.
Publicado: (2022)

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Different Donors in Recipients With Mucopolysaccharidosis
por: Qu, Yuhua, et al.
Publicado: (2022)

Unusual isolated extramedullary relapse of acute lymphoblastic leukemia in the breast despite complete donor hematopoietic chimerism after allogeneic hematopoietic stem cell transplantation
por: Sung, Pack Hyun, et al.
Publicado: (2018)

Overexpression of S100A9 in donor T cells is associated with reconstitution of gut microbiota and outcome of allogeneic hematopoietic stem cell transplantation
por: Kim, Sena, et al.
Publicado: (2023)

Toxoplasma Encephalitis in an Allogeneic Hematopoietic Stem Cell Transplant Recipient in Korea
por: Park, Soo-Kyung, et al.
Publicado: (2012)

Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation
por: Morin-Zorman, Sarah, et al.
Publicado: (2016)

Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?
por: Li, Jiali, et al.
Publicado: (2020)

Efficacy and Safety of Aprepitant in Allogeneic Hematopoietic Stem Cell Transplantation
por: Uchida, Mayako, et al.
Publicado: (2013)

ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- and Long-term Outcomes
por: Valentini, Caterina Giovanna, et al.
Publicado: (2021)

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020)

The Clinical Value of Procalcitonin in the Neutropenic Period After Allogeneic Hematopoietic Stem Cell Transplantation
por: Shan, Meng, et al.
Publicado: (2022)

Reduced immunogenicity of a third COVID-19 vaccination among recipients of allogeneic hematopoietic stem cell transplantation
por: Einarsdottir, Sigrun, et al.
Publicado: (2022)

Immune reconstitution profile after allogeneic hematopoietic stem cell transplantation with post-transplant cyclophosphamide
por: Espinoza-Gutarra, Manuel, et al.
Publicado: (2023)

Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation
por: Chiusolo, Patrizia, et al.
Publicado: (2022)

COVID-19 vaccine-induced adverse events predict immunogenicity among recipients of allogeneic hematopoietic stem cell transplantation
por: Wiktorin, Hanna Grauers, et al.
Publicado: (2022)

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
por: Cui, Qingya, et al.
Publicado: (2021)

Long-term health outcomes of allogeneic hematopoietic stem cell transplantation
por: Kelkar, Amar H., et al.
Publicado: (2023)

Immune reconstitution and survival of patients after allogeneic hematopoietic stem cell transplantation from older donors
por: Jiang, Peiyao, et al.
Publicado: (2022)

A case of donor-derived granulocytic sarcoma after allogeneic hematopoietic stem cell transplantation
por: Jeong, Seong Hyun, et al.
Publicado: (2010)

KIR in Allogeneic Hematopoietic Stem Cell Transplantation: Need for a Unified Paradigm for Donor Selection
por: Dhuyser, Adèle, et al.
Publicado: (2022)

36. Safety and Reactogenicity of the Adjuvanted Recombinant Zoster Vaccine after Allogeneic Hematopoietic Stem Cell Transplantation
por: Baumrin, Emily, et al.
Publicado: (2020)

Long-term remission after allogeneic hematopoietic stem cell transplantation in LPS-responsive beige-like anchor (LRBA) deficiency
por: Seidel, Markus G., et al.
Publicado: (2015)

Pediatric donor cell leukemia after allogeneic hematopoietic stem cell transplantation in AML patient from related donor
por: Bobadilla-Morales, Lucina, et al.
Publicado: (2015)

Successful treatment of myelodysplastic syndrome and Behcet colitis after allogeneic hematopoietic stem cell transplantation
por: Kook, Min-Ha, et al.
Publicado: (2014)

An isolated cardiac relapse after allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia
por: Chang, Kiju, et al.
Publicado: (2017)

Alterations of hemostatic parameters in the early development of allogeneic hematopoietic stem cell transplantation-related complications
por: Han, Yue, et al.
Publicado: (2011)

Allogeneic hematopoietic cell transplantation outcomes in patients with Richter’s transformation
por: Kim, Haesook T., et al.
Publicado: (2021)

Donor‐derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation
por: Hanaki, Ryo, et al.
Publicado: (2021)

Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors
por: Tamaki, Masaharu, et al.
Publicado: (2022)

Paired Donor and Recipient Immunophenotyping in Allogeneic Hematopoietic Stem Cell Transplantation: A Cellular Network Approach
por: Wittenbecher, Friedrich, et al.
Publicado: (2022)

Favorable Short-term Outcome in Deceased Kidney Donor Transplantation
por: Nourbala, M. H., et al.
Publicado: (2012)

BK virus encephalitis without concurrent hemorrhagic cystitis in an allogeneic hematopoietic stem cell transplant recipient
por: Lee, Suk-young, et al.
Publicado: (2013)

Predicting Successful Hematopoietic Stem Cell Collection in Healthy Allogeneic Donors
por: Kayser, Sabine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p5g74jra2tnibh2mlma3454ish